Concepedia

Publication | Open Access

Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database

46

Citations

38

References

2021

Year

Abstract

Neutropenia, superinfections, reactivation of latent infections, hepatitis, and cardiac abnormalities were common ADEs observed that necessitate proper monitoring and reporting.

References

YearCitations

Page 1